BlossomHill Therapeutics, Inc. Common Stock (BLSM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BLSM. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 6 institutions reported holding BLSM, with 1.3 million shares worth $23.3 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 1,027,293 | $19M | NEW |
| Geode Capital Management | 119,176 | $2M | NEW |
| Monashee Investment Management | 80,000 | $1M | NEW |
| Squarepoint Ops | 23,150 | $432K | NEW |
| Citigroup | 1,279 | $24K | NEW |
Full institutional holdings, insider history, and congressional trades for BlossomHill Therapeutics, Inc. Common Stock on SentiSense.